Lab testing giant Quest Diagnostics confirms patients’ personal and health data was compromised during breach
Quest is the latest in a series of healthcare technology companies that have been hacked in recent months.
Covered in this story
Analyst targets on Quest Diagnostics
- Truist Securities: $228 → $250 by Jul 2027 · Hold via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $DGX yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Quest Diagnostics →Summary aggregated from TechCrunch's public RSS feed. The full reporting belongs to TechCrunch — please read it on their site.